Le Lézard
Classified in: Science and technology
Subject: PDT

Zyston Unveils CyberCAST 3.0: A Revolutionary Advancement in Continuous Threat Exposure Management


Zyston, renowned for its pioneering cybersecurity solutions, proudly unveils CyberCAST 3.0, a groundbreaking update to its flagship platform. The newest launch highlights Zyston's steadfast commitment to pioneering cybersecurity program management enabling technology, tackling the ongoing challenge of Continuous Threat Exposure Management for organizations.

DALLAS, May 17, 2024 /PRNewswire-PRWeb/ -- At the heart of CyberCAST 3.0 lies a robust risk management framework and an integrated offensive security capability, enabling organizations to proactively identify, assess, and mitigate cybersecurity risks, fostering integrated risk management to safeguard digital assets effectively.

CyberCAST 3.0 is the industry leader in cybersecurity program management. CyberCAST provides customers with a cybersecurity score and a strategic and tactical roadmap for program improvement. Utilizing AI, CyberCAST is a highly time-efficient and cost-effective solution. - Craig Stamm, Zyston CEO

The new features introduced in CyberCAST 3.0 are set to revolutionize how organizations assess and enhance their cybersecurity posture, offering unparalleled value and efficiency:

1. AI Assist Assessment

Zyston's CyberCAST 3.0 introduces an industry-first AI Assist Assessment feature, setting a new standard in cybersecurity program management technology. This proprietary engine employs real-time analysis of customer policy documents against the NIST CSF 2.0 framework to provide instant responses to the CyberCAST SAQ (Self-Assessment Questionnaire), streamlining compliance processes like never before. By leveraging AI technology, organizations can efficiently evaluate their cybersecurity posture in as little as two minutes, ensuring adherence to industry standards and fortifying defenses against evolving threats with unprecedented speed and accuracy.

2. Integration of NIST Cybersecurity Framework Version 2.0:

CyberCAST is among the first platforms to incorporate the NIST Cybersecurity Framework (CSF) version 2.0, released in February. This integration expands the framework's capabilities, particularly in governance, providing a comprehensive approach to compliance and integrated risk management. Zyston's pioneering implementation ensures that organizations have access to the latest standards and methodologies to strengthen their cybersecurity programs.

3. Guided Self-Assessment Functionality:

Empowering organizations with greater autonomy, CyberCAST 3.0 introduces self-assessment capabilities, previously available only through consulting services. With fewer than 200 questions, users can conduct assessments independently, receiving a projected score before engaging with Zyston's cybersecurity experts. This streamlined process enhances customer engagement, reduces overhead, and accelerates the assessment process, delivering unparalleled value to users in under two minutes.

4. Unified Architecture for Seamless Data Integration:

To streamline operations and enhance user experience, CyberCAST 3.0 features a unified architecture that seamlessly integrates data from the Blue Lava platform. Combining the CyberCAST platform with the recently acquired Blue Lava platform has created a clear industry leader in software-driven cybersecurity program management, empowering organizations to make informed decisions and proactively mitigate cyber risks.

5. Enhanced Board-Targeted Reporting:

Recognizing the need for clear and concise communication with executive leadership and board members, CyberCAST 3.0 introduces board-targeted reporting capabilities. Users can now generate high-quality artifacts directly within the platform, including gauges, historical diagrams, and roadmaps, tailored for executive presentations. This feature facilitates informed decision-making and enables organizations to effectively communicate cybersecurity risks and initiatives to key stakeholders, ensuring continuous threat exposure management is prioritized.

6. Peer Score Comparison:

CyberCAST 3.0 introduces peer score comparison functionality, answering the call from customers eager to benchmark their cybersecurity performance against industry peers. Leveraging a proven model established by Blue Lava, this feature empowers organizations to gain valuable insights into their competitive standing within their respective sectors.

By comparing their cybersecurity posture against industry benchmarks, businesses can strategically allocate resources, identify areas for improvement, and bolster their defenses against evolving threats. In today's ever-evolving digital landscape, CyberCAST 3.0's peer score comparison provides a critical tool for organizations to proactively enhance their cybersecurity resilience and stay ahead of emerging threats.

Zyston's CyberCAST 3.0 represents a significant leap forward in cybersecurity program management technology, empowering organizations to proactively identify, mitigate, and manage cybersecurity risks with confidence. To learn more about CyberCAST 3.0 and Zyston's comprehensive cybersecurity solutions, visit https://www.zyston.com/cybercast-software/.

About Zyston:

Zyston is a leading provider of end-to-end cybersecurity solutions, offering consulting, managed services, and AI-driven software to help businesses build and operate robust information security programs. With a focus on innovation and customer satisfaction, Zyston is dedicated to empowering organizations to safeguard their digital assets and achieve cybersecurity resilience. For more information, visit www.zyston.com.

Media Contact

Jack Aubrey, Zyston LLC, 1 (469) 458-6670, [email protected], https://www.zyston.com/

SOURCE Zyston LLC


These press releases may also interest you

at 10:05
Genmab A/S and BioNTech SE today announced initial data from the Phase 2 GCT1046-04 trial (NCT05117242) evaluating acasunlimab (DuoBody-PD-L1x4-1BB), an investigational bispecific antibody also known as GEN1046/BNT311, as monotherapy and in...

at 10:05
First Ascent Biomedical announced findings from ongoing clinical studies conducted in partnership with Florida International University, examining the company's Functional Precision Medicine (FPM) platform in adult and pediatric patients with...

at 09:35
Tempus, a leader in artificial intelligence and precision medicine, today announces an expansion of its collaboration with AstraZeneca, which leverages Tempus Next to arm physicians with technology that supports the delivery of guideline-directed...

at 09:05
Ankyra Therapeutics, a clinical-stage oncology company developing anchored immunotherapies to improve the therapeutic window for immuno-oncology drugs, announced today that it is presenting a Trial in Progress poster for the phase 1 ANCHOR clinical...

at 08:30
Stay on top of current hot topics through free webinars presented by leading experts in the pharma, biotech, medical device...

at 08:15
Nuvation Bio Inc. , a late clinical-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology, announced that results from the pivotal Phase 2 TRUST-I study conducted in China evaluating taletrectinib, its...



News published on and distributed by: